Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.
Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, Via Orabona 4, 70124 Bari, Italy.
Biomed Res Int. 2019 Mar 17;2019:7168949. doi: 10.1155/2019/7168949. eCollection 2019.
is a common cause of community-acquired pneumonia (CAP). This cross-sectional study aimed to determine the prevalence of macrolide-resistant strains in a convenience series of 234 adult hospitalised and nonhospitalised subjects with a diagnosis of CAP in January 2013 to April 2015 in South Italy.
Respiratory samples were subjected to real-time PCR. In -positive samples, domain V of 23S rRNA was sequenced to detect resistance-conferring point mutations. P1 major adhesion protein typing and multiple loci variable-number tandem repeat analysis (MLVA) were also performed.
Of the 234 samples, 15 (6.4%) were positive for . Three of these had a macrolide-resistant genotype: two and one had A2063G and A2064G mutations, respectively. Fourteen of the 15 strains were subtyped: half had subtype 1 and half had subtype 2. Eight strains underwent MLVA profiling: one each had the J, A, and Z type. The remainder was unclassifiable.
This novel discovery of macrolide-resistant strains in adults with CAP in Italy suggests that there may be increasing circulation of these strains in the population. To facilitate rapid optimization of the antibiotic strategy in Italy, macrolide resistance should be monitored by a surveillance system that is based on molecular methods.
肺炎支原体是社区获得性肺炎(CAP)的常见病因。本横断面研究旨在确定大环内酯类耐药 株在意大利南部 2013 年 1 月至 2015 年 4 月期间便利收集的 234 例住院和非住院成人 CAP 诊断患者中的流行率。
采集呼吸道样本进行实时 PCR。在 阳性样本中,对 23S rRNA 结构域 V 进行测序,以检测耐药相关的点突变。还进行了 P1 主要黏附蛋白分型和多位点可变数串联重复分析(MLVA)。
234 个样本中,有 15 个(6.4%)为 阳性。其中 3 个具有大环内酯类耐药基因型:2 个和 1 个分别具有 A2063G 和 A2064G 突变。15 株中有 14 株进行了亚分型:一半为 1 型,一半为 2 型。8 株进行了 MLVA 分析:1 株为 J 型,1 株为 A 型,1 株为 Z 型。其余的无法分类。
意大利 CAP 成人中发现的新型大环内酯类耐药 株表明,这些菌株在人群中的传播可能越来越多。为了促进意大利抗生素策略的快速优化,应通过基于分子方法的监测系统来监测大环内酯类耐药性。